AMYLIN PHARMACEUTICALS INC Other Nonoperating Expense
AMYLIN PHARMACEUTICALS INC reported Other Nonoperating Expense of $1.94 million for the 3-month period ending 2012-06-30, per its 10-Q filed 2012-08-03.
Discontinued › Income Statement › Other Income
us-gaap:OtherNonoperatingExpense · last filed 2012-08-03
- AMYLIN PHARMACEUTICALS INC other nonoperating expense for the quarter ending 2012-06-30 was $1.94M, a 21455.56% increase year-over-year.
- AMYLIN PHARMACEUTICALS INC other nonoperating expense for the quarter ending 2012-03-31 was $45.15M, a 428.24% increase year-over-year.
- AMYLIN PHARMACEUTICALS INC other nonoperating expense for the quarter ending 2011-12-31 was $16.33M, a 70.93% increase year-over-year.
- AMYLIN PHARMACEUTICALS INC other nonoperating expense for the quarter ending 2011-09-30 was $6.27M, a 1.12% decline year-over-year.
- AMYLIN PHARMACEUTICALS INC other nonoperating expense for fiscal 2011 was $38.09M, a 35.70% increase from fiscal 2010.
- AMYLIN PHARMACEUTICALS INC other nonoperating expense for fiscal 2010 was $28.07M, a 45.44% increase from fiscal 2009.
- AMYLIN PHARMACEUTICALS INC other nonoperating expense for fiscal 2009 was $19.30M.
| Period end | Other Nonoperating Expense 3 month | Other Nonoperating Expense 3 month as first filed | Other Nonoperating Expense 6 month | Other Nonoperating Expense 6 month as first filed | Other Nonoperating Expense 9 month | Other Nonoperating Expense 12 month |
|---|---|---|---|---|---|---|
| 2012-06-30 | $1.94M 10-Q · filed 2012-08-03 | $5.84M 10-Q · filed 2012-08-03 | $63.42M derived: sum of 3 quarters · filed 2012-08-03 | $69.69M derived: sum of 4 quarters · filed 2012-08-03 | ||
| 2012-03-31 | $45.15M 10-Q · filed 2012-05-07 | $61.48M derived: sum of 2 quarters · filed 2012-05-07 | $67.75M derived: sum of 3 quarters · filed 2012-05-07 | $67.76M derived: sum of 4 quarters · filed 2012-08-03 | ||
| 2011-12-31 | $16.33M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22 | $22.60M derived: sum of 2 quarters · filed 2012-02-22 | $22.61M derived: sum of 3 quarters · filed 2012-08-03 | $38.09M 10-K · filed 2012-02-22 | ||
| 2011-09-30 | $6.27M 10-Q · filed 2011-10-28 | $6.28M derived: sum of 2 quarters · filed 2012-08-03 | $21.76M 10-Q · filed 2011-10-28 | $24.38M derived: sum of 4 quarters · filed 2012-08-03 | ||
| 2011-06-30 | $9.00K 10-Q · filed 2012-08-03 | $6.95M 10-Q · filed 2011-08-08 | $192.00K 10-Q · filed 2012-08-03 | $15.49M 10-Q · filed 2011-08-08 | $18.11M derived: sum of 3 quarters · filed 2012-08-03 | $24.45M derived: sum of 4 quarters · filed 2012-08-03 |
| 2011-03-31 | $8.55M 10-Q · filed 2012-05-07 | $18.10M derived: sum of 2 quarters · filed 2012-05-07 | $24.44M derived: sum of 3 quarters · filed 2012-05-07 | $30.54M derived: sum of 4 quarters · filed 2012-05-07 | ||
| 2010-12-31 | $9.55M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22 | $15.89M derived: sum of 2 quarters · filed 2012-02-22 | $21.99M derived: sum of 3 quarters · filed 2012-02-22 | $28.07M 10-K · filed 2012-02-22 | ||
| 2010-09-30 | $6.34M 10-Q · filed 2011-10-28 | $12.44M derived: sum of 2 quarters · filed 2011-10-28 | $18.52M 10-Q · filed 2011-10-28 | |||
| 2010-06-30 | $6.10M 10-Q · filed 2011-08-08 | $12.18M 10-Q · filed 2011-08-08 | ||||
| 2009-12-31 | $19.30M 10-K · filed 2012-02-22 |